Status:

NOT_YET_RECRUITING

Study on the Effectiveness of Berlin Dissexuality Therapy as Part of the Model Project in Accordance With §65d SBG V

Lead Sponsor:

Charite University, Berlin, Germany

Collaborating Sponsors:

Hannover Medical School

Heinrich-Heine University, Duesseldorf

Conditions:

Paedophilia

Hebephilia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The main goal of this clinical trial is to learn if psychotherapy works to reduce consumption of child abuse imagages.

Eligibility Criteria

Inclusion

  • Age at first presentation minimum 18 years
  • Voluntary consent to participation on the part of the participant
  • At the time of inclusion, no contact with the justice system (ongoing investigation, ongoing criminal proceedings, ongoing prison sentence) due to sexually abusive behavior towards children
  • Sexually conspicuous behavior and/or fantasies or impulses that indicate the presence of a pedophilic and/or hebephilic preference disorder.
  • An offer of treatment is made when a suspected diagnosis is confirmed or the diagnosis is confirmed
  • Feared or recent use of abusive images
  • Sufficient knowledge of German
  • Voluntary participation in the study and checking the checkbox in the informed consent form before starting participation

Exclusion

  • Age under 18 years
  • Lack of consent on the part of the patient
  • Exclusion of the presence of a pedophilic and/or hebephilic preference disorder
  • Current legal status in the sense of an ongoing investigation or criminal proceedings due to sexually assaultive behavior towards children
  • Severe comorbidities: unstable psychotic disorder, organic brain damage, reduced intellectual capacity (IQ below 70), untreated drug or alcohol addiction or persistent harmful use
  • Current risk of child sexual abuse and or child sexual abuse that occurred less than 15 years before the start of the study
  • An antiandrogenic medication or an opiate antagonist, during therapy start taking a serotonin reuptake inhibitor.

Key Trial Info

Start Date :

September 16 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06607042

Start Date

September 16 2024

End Date

December 31 2025

Last Update

September 23 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.